Venture Capital · Copenhagen (Denmark) · Founded 2007
Sunstone Life Science Ventures is an independent European venture capital firm focused on early-stage life science companies developing novel therapeutics for humans. They invest in opportunities targeting unmet medical needs in commercially attractive markets, prioritizing companies with strong management teams and suitable for M&A exits.
Series A, Series B
BioTech
F2G, IO Biotech, Minervax, Oxthera, Step Pharma, Synendos, Acarix, Alligator Bioscience, Arcoma, Ascelia, Cantargia, Egalet, Evolva, Follicum, Galecto, Inc., Nuevolution, Orphazyme, Zealand Pharma, Action Pharma, Euro Diagnostica, Forendo Pharma, Jurag Separation, Precisense, Prexton Therapeutics, Rigontec, Santaris Pharma, Symphogen, Zymenex, Vaximm, Stipe Therapeutics